Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer

R (Rosa) Hoekstra; FYFL de Vos; Ferry Eskens; JA Gietema; Ate van der Gaast; HJM Groen; RA Knight; RA Carr; RA Humerickhouse; Jaap Verweij; EGE de Vries

Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer

R (Rosa) Hoekstra, FYFL de Vos, Ferry Eskens, JA Gietema, Ate van der Gaast, HJM Groen, RA Knight, RA Carr, RA Humerickhouse, Jaap Verweij, EGE de Vries

Research output: Contribution to journal › Article › Academic › peer-review

88 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	5188-5197
Number of pages	10
Journal	Japanese Journal of Clinical Oncology
Volume	23
Issue number	22
Publication status	Published - 2005

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Hoekstra, R., de Vos, FYFL., Eskens, F., Gietema, JA., van der Gaast, A., Groen, HJM., Knight, RA., Carr, RA., Humerickhouse, RA., Verweij, J., & de Vries, EGE. (2005). Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer. Japanese Journal of Clinical Oncology, 23(22), 5188-5197.

@article{aea63aa401b54fe5a71fee533903362d,

title = "Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer",

author = "Hoekstra, {R (Rosa)} and {de Vos}, FYFL and Ferry Eskens and JA Gietema and {van der Gaast}, Ate and HJM Groen and RA Knight and RA Carr and RA Humerickhouse and Jaap Verweij and {de Vries}, EGE",

year = "2005",

language = "Undefined/Unknown",

volume = "23",

pages = "5188--5197",

journal = "Japanese Journal of Clinical Oncology",

issn = "0368-2811",

publisher = "Oxford University Press",

number = "22",

}

Hoekstra, R, de Vos, FYFL, Eskens, F, Gietema, JA, van der Gaast, A, Groen, HJM, Knight, RA, Carr, RA, Humerickhouse, RA, Verweij, J & de Vries, EGE 2005, 'Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer', Japanese Journal of Clinical Oncology, vol. 23, no. 22, pp. 5188-5197.

Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer. / Hoekstra, R (Rosa); de Vos, FYFL; Eskens, Ferry et al.
In: Japanese Journal of Clinical Oncology, Vol. 23, No. 22, 2005, p. 5188-5197.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer

AU - Hoekstra, R (Rosa)

AU - de Vos, FYFL

AU - Eskens, Ferry

AU - Gietema, JA

AU - van der Gaast, Ate

AU - Groen, HJM

AU - Knight, RA

AU - Carr, RA

AU - Humerickhouse, RA

AU - Verweij, Jaap

AU - de Vries, EGE

PY - 2005

Y1 - 2005

M3 - Article

SN - 0368-2811

VL - 23

SP - 5188

EP - 5197

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

IS - 22

ER -